RCKT icon

Rocket Pharmaceuticals
RCKT

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.5
79% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Goldman Sachs
Goldman Sachs
Richard Law
100% 1-yr RCKT win rate
2 Mar ‘26 1 month ago
Cantor Fitzgerald
Cantor Fitzgerald
Josh Schimmer
67% 1-yr RCKT win rate
27 Feb ‘26 1 month ago